175 related articles for article (PubMed ID: 35267117)
1. Treatment of vascular graft infections: gentamicin-coated ePTFE grafts reveals strong antibacterial properties in vitro.
Lazic I; Obermeier A; Dietmair B; Kempf WE; Busch A; Tübel J; Schneider J; von Eisenhart-Rothe R; Biberthaler P; Burgkart R; Pförringer D
J Mater Sci Mater Med; 2022 Mar; 33(3):30. PubMed ID: 35267117
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic-coated ePTFE decreases graft colonization and neointimal hyperplasia.
Fischer PE; Schroeppel TJ; Fabian TC; deRijk WG; Edwards NM; Magnotti LJ; Doty DH; Croce MA
J Surg Res; 2009 Oct; 156(2):199-204. PubMed ID: 19481768
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
4. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Heparan Sulfate-Like Coated ePTFE Grafts Reduce In-graft Neointimal Hyperplasia in Ovine Carotids.
Wulff B; Stahlhoff S; Vonthein R; Schmidt A; Sigler M; Torsello GB; Herten M
Ann Vasc Surg; 2017 Apr; 40():274-284. PubMed ID: 28163179
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model.
Bastijanic JM; Marchant RE; Kligman F; Allemang MT; Lakin RO; Kendrick D; Kashyap VS; Kottke-Marchant K
J Vasc Surg; 2016 Jun; 63(6):1620-1630.e4. PubMed ID: 25827964
[TBL] [Abstract][Full Text] [Related]
9. Novel fatty acid gentamicin salts as slow-release drug carrier systems for anti-infective protection of vascular biomaterials.
Obermeier A; Matl FD; Schwabe J; Zimmermann A; Kühn KD; Lakemeier S; von Eisenhart-Rothe R; Stemberger A; Burgkart R
J Mater Sci Mater Med; 2012 Jul; 23(7):1675-83. PubMed ID: 22476651
[TBL] [Abstract][Full Text] [Related]
10. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
11. Comparing the endothelialisation of extracellular matrix bioscaffolds with coated synthetic vascular graft materials.
Coakley DN; Shaikh FM; O'Sullivan K; Kavanagh EG; Grace PA; Walsh SR; McGloughlin TM
Int J Surg; 2016 Jan; 25():31-7. PubMed ID: 26578107
[TBL] [Abstract][Full Text] [Related]
12. Synthetic ePTFE grafts coated with an anti-CD133 antibody-functionalized heparin/collagen multilayer with rapid in vivo endothelialization properties.
Lu S; Zhang P; Sun X; Gong F; Yang S; Shen L; Huang Z; Wang C
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7360-9. PubMed ID: 23859593
[TBL] [Abstract][Full Text] [Related]
13. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study.
Akers DL; Du YH; Kempczinski RF
J Vasc Surg; 1993 Jul; 18(1):10-5. PubMed ID: 8326650
[TBL] [Abstract][Full Text] [Related]
14. New anti-infective coatings of medical implants.
Matl FD; Obermeier A; Repmann S; Friess W; Stemberger A; Kuehn KD
Antimicrob Agents Chemother; 2008 Jun; 52(6):1957-63. PubMed ID: 18362194
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of gentamicin palmitate against high concentrations of Staphylococcus aureus.
Kittinger C; Marth E; Windhager R; Weinberg AM; Zarfel G; Baumert R; Felisch S; Kuehn KD
J Mater Sci Mater Med; 2011 Jun; 22(6):1447-53. PubMed ID: 21556977
[TBL] [Abstract][Full Text] [Related]
16. Prosthetic vascular conduit in contaminated fields: a new technology to decrease ePTFE infections.
Fischer PE; Fabian TC; deRijk WG; Edwards NM; DeCuypere M; Landis RM; Barnard DL; Magnotti LJ; Croce MA
Am Surg; 2008 Jun; 74(6):524-8; discussion 528-9. PubMed ID: 18556995
[TBL] [Abstract][Full Text] [Related]
17. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides.
Walluscheck KP; Steinhoff G; Kelm S; Haverich A
Eur J Vasc Endovasc Surg; 1996 Oct; 12(3):321-30. PubMed ID: 8896475
[TBL] [Abstract][Full Text] [Related]
18. In vivo biocompatibility and hemocompatibility of a polytetrafluoroethylene small diameter vascular graft modified with sulfonated silk fibroin.
Zhang J; Huang H; Ju R; Chen K; Li S; Wang W; Yan Y
Am J Surg; 2017 Jan; 213(1):87-93. PubMed ID: 27829496
[TBL] [Abstract][Full Text] [Related]
19. Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models.
Lumsden AB; Chen C; Coyle KA; Ofenloch JC; Wang JH; Yasuda HK; Hanson SR
J Vasc Surg; 1996 Nov; 24(5):825-33. PubMed ID: 8918330
[TBL] [Abstract][Full Text] [Related]
20. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization.
Begovac PC; Thomson RC; Fisher JL; Hughson A; Gällhagen A
Eur J Vasc Endovasc Surg; 2003 May; 25(5):432-7. PubMed ID: 12713782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
